VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
MOHMolina Healthcare, Inc.
$195.37$10.2B
Research
OverviewAnalysis
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksMOHPrice Target
MOH logo

Molina Healthcare, Inc. (MOH) Price Target Analysis

Updated Jun 18, 2026
Analyst Rating: Buy
Based on 38 analysts

10.1% Above Target

MOH trades 10.1% above Wall Street's consensus target of $175.55.

Current Price$195.37
Average Target$175.55
Target
Current
Low$124.00
Median$167.00
High$224.00

Analyst Target Range

Forward P/E38.0x
(Growth Premium)
PEG Ratio—
Implied Growth+39.3%
(High Growth)
Analyst Spread57.0%
(Moderate)

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$195.37
Consensus$175.55
High$224.00
Low$124.00

Consensus Scenario Assumptions

The base valuation assumes MOH achieves its forward estimates and maintains a stable P/E multiple of 38.0x. This scenario reflects the blended consensus of 38 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings Distribution

Breakdown of 38 published analyst recommendations for MOH

39% hold / mixed conviction
+14
BearishBullish
Weighted analyst sentiment score based on 38 ratings
ConsensusBuy
Coverage38 Analysts
Net Score+14
Bull / Bear45% / 16%
Strong Buy00%
Buy1745%
Hold1539%
Sell616%
Strong Sell00%
Strong Buy
00%
Buy
1745%
Hold
1539%
Sell
616%
Strong Sell
00%
Recommendation Mix45% Buy · 39% Hold · 16% Sell
Buy (17)Hold (15)Sell (6)

MOH Price Target Analysis

Updated June 21, 2026

As of June 21, 2026, Molina Healthcare, Inc. (MOH) has a Wall Street consensus price target of $175.55, based on estimates from 38 covering analysts. With the stock currently trading at $195.37, this represents a potential downside of -10.1%. The company has a market capitalization of $10.18B.

Analyst price targets range from a low of $124.00 to a high of $224.00, representing a 57% spread in expectations. The median target of $167.00 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.

The current analyst consensus rating is Buy, with 17 analysts rating the stock as a Buy or Strong Buy,15 rating it Hold, and 6 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.

From a valuation perspective, MOH trades at a trailing P/E of 21.9x and forward P/E of 38.0x. Analysts expect EPS to grow +39.3% over the next year.

Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $294.97, with bear and bull scenarios of $185.83 and $388.65 respectively. Model confidence stands at 51/100, reflecting moderate uncertainty in projections.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside
+6.3%
Industry Consensus
Avg Forward P/E
30.5x
(Growth Premium)
Peers with Coverage
10 / 10
Active Analyst Tracking
CompanyMarket CapPriceTargetUpside PotentialRatingFwd P/EAnalysts
CNC logo
CNCCentene Corporation
$30.1B$61.02$59.00
-3.3%
Buy17.5x43
ALHC logo
ALHCAlignment Healthcare, Inc.
$4.5B$21.86$24.33
+11.3%
Buy118.7x16
UNH logo
UNHUnitedHealth Group Incorporated
$363.9B$400.96$425.81
+6.2%
Buy21.8x52
CVS logo
CVSCVS Health Corporation
$125.4B$98.32$103.64
+5.4%
Buy13.3x41
ELV logo
ELVElevance Health Inc.
$84.4B$388.50$415.19
+6.9%
Buy14.5x37
HUM logo
HUMHumana Inc.
$43.3B$360.65$298.50
-17.2%
Hold40.8x44
CI logo
CICigna Corporation
$73.6B$279.27$340.91
+22.1%
Buy9.2x39
OSCR logo
OSCROscar Health, Inc.
$7.4B$28.40$24.20
-14.8%
Hold31.5x11
MCK logo
MCKMcKesson Corporation
$90.2B$750.63$994.86
+32.5%
Buy17.0x31
CAH logo
CAHCardinal Health, Inc.
$52.2B$221.77$253.38
+14.3%
Buy20.6x33

MOH — Frequently Asked Questions

Quick answers to the most common questions about buying MOH stock.

What is the MOH stock price target for 2026?

MOH's consensus price target is $175.55, -10.1% below the current price of $195.37. The 38 analysts tracking MOH see downside risk at present valuations.

Is MOH a buy, sell, or hold?

MOH has a consensus rating of "Buy" based on 38 Wall Street analysts. The rating breakdown is mixed, with 15 Hold ratings making up the largest segment. The consensus 12-month price target of $175.55 implies -10.1% downside from current levels.

Is MOH stock overvalued or undervalued?

At a forward P/E of 38.0349x, MOH trades at a premium valuation. The consensus price target of $175.55 (-10.1% downside) suggests analysts may view current valuations as stretched.

How high can MOH stock go?

The most bullish Wall Street analyst has a price target of $224 for MOH, while the most conservative target is $124. The consensus of $175.55 represents the median expectation. Our quantitative valuation model projects a bull case target of $389 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

How many analysts cover MOH stock?

MOH is heavily covered by Wall Street, with 38 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 17 have Buy ratings, 15 recommend Hold, and 6 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the MOH stock forecast?

The 12-month MOH stock forecast based on 38 Wall Street analysts shows a consensus price target of $175.55, with estimates ranging from $124 (bear case) to $224 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $295, with bear/bull scenarios of $186/$389.

What is MOH's fair value based on fundamentals?

Our quantitative valuation model calculates MOH's fair value at $295 (base case), with a bear case of $186 and bull case of $389. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 51/100.

What is MOH's forward P/E ratio?

MOH trades at a forward P/E ratio of 38.0x based on next-twelve-months earnings estimates compared to a trailing P/E of 21.9x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy MOH stock?

Analysts are cautious on MOH, with 6 Sell ratings and a price target of $175.55 (-10.1% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do MOH price targets vary so much?

MOH analyst price targets range from $124 to $224, a 57% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $175.55 consensus represents the middle ground. Our model's $186-$389 range provides an independent fundamental perspective.

Consensus-Based Analysis Tools

Full Stock Analysis

Deep dive into MOH consensus models and risk factors.

View Analysis

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare